Anaphylaxis Prediction and Tailored Medicine Prescription System Using CNN-Based Tabular Data Analysis

Abstract

Allergic diseases encompass a wide range of conditions in which the immune system reacts abnormally to harmless substances, leading to various symptoms and health complications. Anaphylaxis is a serious life-threatening generalized or systemic hypersensitivity reaction.[1] Mainly it is thought to be a serious systemic hypersensitivity reaction that is usually rapid in onset and may cause death.[2] It is triggered by exposure to specific allergens, such as certain foods, medications, insect stings, or latex.[3] The conventional approach to diagnosing anaphylaxis involves in-person consultations with healthcare professionals, including physicians, allergists, and immunologists.[4] However, this process can be time-consuming, costly, and dependent on the availability of specialized medical expertise. Identifying anaphylaxis as positive or negative is complex due to the similarity of its symptoms with common ailments, requiring the physician's expertise. However, manual identification can cause accuracy issues, leading to incorrect diagnoses and prescriptions. To address these challenges and provide a more efficient disease diagnosis system, this research aims to harness machine learning techniques. Specifically, a CNN-based analysis is employed to predict whether a patient has anaphylaxis. Moreover, the system's functionality extends beyond diagnosis. If anaphylaxis is positively identified, the system initiates the process of recommending the administration of adrenaline. In the case of patients aged less than 12, a specialized mathematical equation is applied to calculate the appropriate dosage of adrenaline based on the patient's age. Conversely, if the system determines a negative anaphylaxis diagnosis, it reevaluates the input symptoms and matches them with suitable specialists. The system maintains a repository of physicians categorized by their areas of expertise, allowing it to output both the specialist's field and the name of the corresponding physician for patient referral.

Country : Sri Lanka

1 L.M. Dilanka Matheesha Rajapakse2 H.M. Samadhi Chathuranga Rathnayake3 Sanjeevi Chandrasiri

  1. Department of Information Technology, Faculty of Computing, Sri Lanka Institute of Information Technology, Sri Lanka
  2. Lecturer, Department of Information Technology, Faculty of Computing, Sri Lanka Institute of Information Technology, Sri Lanka
  3. Lecturer, Department of Information Technology, Faculty of Computing, Sri Lanka Institute of Information Technology, Sri Lanka

IRJIET, Volume 7, Issue 11, November 2023 pp. 430-435

doi.org/10.47001/IRJIET/2023.711058

References

  1. F. E. R. Simons et al., "World allergy organization guidelines for the assessment and management of anaphylaxis," World Allergy Organization Journal, vol. 4, no. 2, pp. 13-37, 2011.
  2. P. J. Turner et al., "Time to revisit the definition and clinical criteria for anaphylaxis?," World Allergy Organization Journal, vol. 12, no. 10, 2019.
  3. R. Pawankar, G. Canonica, S. Holgate, and R. Lockey, "WAO, white book on allergy Milwaukee (WI)," World Allergy Organization, 2011.
  4. L. Harduar-Morano, M. R. Simon, S. Watkins, and C. Blackmore, "Algorithm for the diagnosis of anaphylaxis and its validation using population-based data on emergency department visits for anaphylaxis in Florida," Journal of allergy and clinical immunology, vol. 126, no. 1, pp. 98-104. e4, 2010.
  5. H. A. Sampson et al., "Second symposium on the definition and management of anaphylaxis: summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium," Journal of Allergy and Clinical Immunology, vol. 117, no. 2, pp. 391-397, 2006.
  6. R. L. Campbell et al., "Evaluation of national institute of allergy and infectious diseases/food allergy and anaphylaxis network criteria for the diagnosis of anaphylaxis in emergency department patients," Journal of Allergy and Clinical Immunology, vol. 129, no. 3, pp. 748-752, 2012.
  7. O. Isakov, I. Dotan, and S. Ben-Shachar, "Machine learning–based gene prioritization identifies novel candidate risk genes for inflammatory bowel disease," Inflammatory bowel diseases, vol. 23, no. 9, pp. 1516-1523, 2017.
  8. M. J. Matasar and A. I. Neugut, "Epidemiology of anaphylaxis in the United States," Current allergy and asthma reports, vol. 3, no. 1, pp. 30-35, 2003.
  9. D. A. Sclar and P. L. Lieberman, "Anaphylaxis: underdiagnosed, underreported, and undertreated," The American journal of medicine, vol. 127, no. 1, pp. S1-S5, 2014.
  10. O. Shahid et al., "Machine learning research towards combating COVID-19: Virus detection, spread prevention, and medical assistance," Journal of Biomedical Informatics, vol. 117, p. 103751, 2021.
  11. T. Latchoumi, J. Dayanika, and G. Archana, "A comparative study of machine learning algorithms using quick-witted diabetic prevention," Annals of the Romanian Society for Cell Biology, pp. 4249-4259, 2021.
  12. K. Goto et al., "Novel machine learning method allerStat identifies statistically significant allergen-specific patterns in protein sequences," Journal of Biological Chemistry, vol. 299, no. 6, 2023.
  13. A.Muraro et al., "EAACI guidelines: anaphylaxis (2021 update)," Allergy, vol. 77, no. 2, pp. 357-377, 2022.
  14. F. E. R. Simons and H. A. Sampson, "Anaphylaxis: unique aspects of clinical diagnosis and management in infants (birth to age 2 years)," Journal of Allergy and Clinical Immunology, vol. 135, no. 5, pp. 1125-1131, 2015.